INNOBIO

Dalian, China Founded: 2003 • Age: 23 yrs
Develops innovative technologies for a suite of nutritional raw materials.

About INNOBIO

INNOBIO is a company based in Dalian (China) founded in 2003. It operates as a B2B. INNOBIO operates in a competitive market with competitors including Enzymotec, The DuPont Nutrition and Health, Zarbees, TerraVia and Advanced Enzyme Technologies, among others.

  • Headquarter Dalian, China
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website innobio.cn

Competitors of INNOBIO

INNOBIO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzymotec, The DuPont Nutrition and Health, Zarbees, TerraVia and Advanced Enzyme Technologies, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
enzymotec.com1998Kfar Saba, Israel$21M–
Bio-functional lipid ingredients are developed for nutritional and pharmaceutical uses.
danisco.com1989Copenhagen, Denmark$880,0851,007
Manufactures a range of health ingredients
zarbees.com2008Draper, United States$28.28M–
Natural cough remedies and wellness products are developed by Zarbees.
terravia.com2003San Francisco, United States$60M–
Algae-based specialty ingredients are manufactured and supplied for food applications.
advancedenzymes.com1989Thane, India–689
Enzymes are manufactured for nutrition, food, feed, and textile industries.
zivobioscience.com1983Keego Harbor, United States$962,00010
Bioactive compounds from algal strain
kaffebueno.com2016Copenhagen, Denmark$8.13M–
Coffee beans are supplied by Kaffe Bueno in multiple categories.
victoryhempfoods.com2014Louisville, United States$7.62M17
Hemp-based foods including seeds, oil, honey, and protein are provided.
interhealthusa.com1987Benicia, United States–33
Nutraceutical and specialty ingredients are researched, developed, and supplied.
Premium access

Detailed competitors of INNOBIO

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Innobio

Premium access

Complete news archive for INNOBIO

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to INNOBIO

10 companies that operate in the same segment as INNOBIO (Traditional Health & Nutrition), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United States–USD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Oral solid drug delivery systems are manufactured and developed.
1985Mumbai, Maharashtra, IndiaUSD 42.49 MUSD 89.42 M962
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United States–USD 5.1 B13,500
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals.
1901Petah Tikva, Central District, IsraelUSD 500 MUSD 18.74 B51,792
Generic, semi-solid, and liquid dosage forms are manufactured.
1990Bengaluru, Karnataka, India–USD 508.93 M5,180
Pharmaceutical products are developed and marketed globally.
2009Montville, New Jersey, United StatesUSD 155.92 M––
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
1983Mumbai, Maharashtra, India–USD 6.21 B25,870
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations
1991Delhi, Delhi, IndiaUSD 367.2 MUSD 1.52 B21,320
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt.
1967Mumbai, Maharashtra, India–USD 353.53 M3,410
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about INNOBIO

INNOBIO was founded in 2003.

INNOBIO is headquartered in Dalian, China. It is registered at Dalian, Liaoning, China.

INNOBIO operates with a B2B model, focusing on promoting health and well-being, nutrition, raw materials, and innovative technologies. Develops innovative technologies for a suite of nutritional raw materials. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

INNOBIO's top competitors include Advanced Enzyme Technologies, Zivo Bioscience and Enzymotec.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available